Becker’s Healthcare Podcast

Episode: Inside Healthcare Private Equity and Policy with Dr. David Klein and Joseph Mercer of Marwood Group

Date: February 24, 2026
Host: Scott Becker
Guests: Dr. David Klein (Senior Advisor, Marwood Group; Critical Care Physician, University of Toronto) & Joseph Mercer (Managing Director, Marwood Group, DC)

Episode Overview

This episode explores the intersection between healthcare private equity and policy changes, focusing on how regulatory shifts influence deal-making, compliance, and operational strategy in healthcare. Featuring insights from Marwood Group leaders Dr. David Klein and Joseph Mercer, the conversation delves into private equity diligence practices, major trends in healthcare investing, evolving compliance demands, and career advice for emerging leaders in the field.

Key Discussion Points & Insights

1. Introduction to Marwood Group & Guest Backgrounds

• Marwood’s Evolution & Role

  • Founded over 25 years ago to bridge healthcare policy understanding between DC and Wall Street, especially to prevent surprises like those caused by the Balanced Budget Act of 1997.
    “Started as a little bit of like, a, let's make a better connection for health care policy between D.C. and Wall Street... Instead maybe let's, let's not advance. Obviously that's a market that's grown quite a bit.”—Joe Mercer (01:33)
  • Now a premier firm for private equity diligence in healthcare serving both investors and operators with deep research, regulatory, strategy, and compliance insights.

• Joseph Mercer’s Journey

  • Background at CMS implementing the ACA, now leads federal regulatory and legislative issue analysis at Marwood, with a focus on private equity diligence.

• Dr. David Klein’s Path

  • Practicing critical care physician and academic in Toronto; previous roles as healthcare operating partner in private equity, McKinsey health practice leader, and advisor to governments.
  • Emphasizes a “triangle of healthcare investing” combining clinical need, business/finance, and policy.
    “If you've ever been to an investment committee with a healthcare deal and the first three risks aren't regulatory or stroke of the pen in one way or another, then you're probably not looking at the deal the right way.”—Dr. David Klein (08:53)

2. Anatomy of a Marwood Diligence Project

• Standard engagement: 3–4 weeks, deeply interactive with PE sponsors, focus on identifying known and unknown risks/opportunities across regulatory and strategic dimensions.
• Outcome: Deliverables range from concise 25-slide decks to extensive 350-slide reports, tailored by deal complexity and client need.
• Teams work cross-functionally, blending payer, strategy, and policy expertise.
  “It’s an interactive process across the organization... some could be 25 slides... or it could be 350 depending on the scope.”—Joseph Mercer (04:47)

3. Major Healthcare Investment Trends & Policy Hotspots (2026)

Dr. Klein's Investment and Clinical Perspective (09:40):

• Shift to Lower-Cost Care Settings
  • Accelerated by COVID, sustained focus on home care, hospice, and outside-institution models, underpinned by tech (IT, remote monitoring, data).
• Fiscal Strain & Technological Optimization
  • Emphasis on revenue cycle management, using AI and tech to drive workflow/cost improvements.
• Alignment of Payment & Outcomes
  • Growing attention to value-based, government-paid, or employer health models that tie dollars more closely to quality/outcomes over fee-for-service.

Joseph Mercer’s Policy Lens (11:45):

• State Budget & Medicaid Pressures
  • “One Big Beautiful Bill Act” impacting state revenue and Medicaid costs, especially aging population services; states bracing for further budget and regulatory shifts in 2027–2028.
  • Caution on “defensive” investments like ABA or personal care services—regulatory action (e.g. fraud crackdown in MN) reveals even these have risk.
• Medicare Advantage & Value-Based Care
  • Trump administration's significant regulatory changes, new opportunities in successor models (e.g. the Lead model, Access model) but existing players face operational and compliance headwinds.
  • Smaller VBC players may benefit as big players reliant on older regulatory advantages get pinched.
  • Increased attention to how MA plans are using outcome-oriented measures to drive provider and VBC partner performance. “Regulatory changes are forcing operational considerations and potentially presenting opportunities... but also present some risks to more established players.”—Joseph Mercer (15:46)

4. Where’s the Action in 2026? Focus Areas for Investors & Marwood’s Clients (16:11)

• Services Are Still Hot: “Payer, pharma, provider services” remain focus areas; physician practice management (PPM) re-attracting cautious interest but now in fragmented markets.
• Revenue Cycle Management (RCM) & HIT
  • RCM vendors, especially those helping with No Surprises Act independent dispute resolution (IDR), are seeing high demand—valued for supporting both large and smaller providers in a changing payment environment.
• Compliance as a Central Concern
  • Intensified by recent policy swings and enforcement actions.
    “Any organization right now that's operating in the health care environment is feeling a tremendous amount of, of scrutiny around compliance.”—Dr. David Klein (17:42)

5. Optimism for Market Activity & Policy Stabilization

• Breaking the Logjam (18:41)
  • Dr. Klein anticipates increased deal flow and more favorable transaction multiples in 2026 as the regulatory/policy environment stabilizes.
  • Less volatility expected as stakeholders adjust to recent reforms and the industry processes previous “wild swings” (e.g., under first Trump term).
• Stable = Investable
  • Investors gravitate to segments where risks are bracketable and regulatory ground is more solid (“where there's been a little bit more stability for longer”—Mercer, 21:55).
• No Surprises Act’s Impact
  • Specific attention to IDR processes as a source of attractive, stable revenue for providers and adjacent HIT vendors.

6. Career & Leadership Advice

Dr. David Klein (23:12)

• Play the Long Game: Continuously acquire new skills and experiences.
• Put Yourself Where You Don’t Belong: Seek learning by entering new rooms and circles; exposes you to bigger ideas and leadership thinking.
  • “Find ways to put yourself in rooms that you don’t belong... That’s really allowed me to learn things and learn the inner workings of business and medicine.”—Dr. Klein (23:35)
• Sports Wisdom: “Skate to where the puck is going, not where it is.”—Wayne Gretzky

Joseph Mercer (24:40)

• Be Curious, Learn From Others
  • “Who around me knows this better and how can I learn?”—humility and bridging knowledge from others is essential.
• Don’t Specialize Too Narrowly Too Soon
  • Embrace opportunities to work across more than one area; Marwood’s breadth allowed new growth and leadership.
  • “The number one piece of advice: be curious. And number two, really take advantage of the people around you that might know one area better. It’s an opportunity…”—Joseph Mercer (25:40)

Notable Quotes & Memorable Moments

• “If you’ve ever been to an investment committee with a healthcare deal and the first three risks aren’t regulatory or stroke of the pen in one way or another, then you’re probably not looking at the deal the right way.”
  — Dr. David Klein (08:53)

• “Any organization right now that’s operating in the health care environment is feeling a tremendous amount of scrutiny around compliance.”
  — Dr. David Klein (17:42)

• “I would love to say, oh, we’ll have less volatility... but going into JPM… in the week prior there was a, you know, …Minnesota and fraud and the potential of contagion... It was all I talked about for two days in an unexpected manner.”
  — Joseph Mercer (20:40)

• “Find ways to put yourself in rooms that you don’t belong.”—Dr. David Klein (23:35)

Important Timestamps

• 00:47: Joe Mercer’s background & Marwood Group evolution
• 03:01: Nature and process of Marwood diligence projects
• 05:29: Dr. Klein’s clinical, business, and policy-driven career narrative
• 09:40: Dr. Klein’s top 3 trends in healthcare investment
• 11:45: Joe Mercer’s perspective on state budgets, Medicaid, Medicare Advantage, and regulatory environments
• 16:11: Sectors Marwood’s clients are most focused on now
• 17:38: Compliance as a central concern for portfolio companies (Dr. Klein)
• 18:41: Dr. Klein’s outlook for market activity and stabilization
• 20:35: Mercer on market “volatility” and where investment interest is strongest
• 23:12-25:55: Career and leadership advice from both guests

Tone & Language

The conversation is collegial, fast-paced, and rich with industry anecdotes. Both guests blend clinical and policy perspectives—offering tangible advice to leaders, with analogies to hockey and golf for lightness and relatability.

Summary Takeaway

This episode provides a nuanced lens into the ways in which policy shifts and regulatory volatility shape every facet of healthcare investing and deals. Marwood Group’s leaders reveal how combining deep sector expertise across clinical, financial, and policy domains helps investors and operators navigate compliance and risk, and how curiosity, humility, and versatility are central to career success in a complex, ever-evolving industry.